Introduction {#h0.0}
============

The detailed study of virulence proteins is critical for understanding how bacterial pathogens cause disease. The use of inducible genetic control elements has facilitated the study and understanding of gene function in many species of bacteria. Many genetic tools exist for such studies of common model organisms such as *Escherichia coli* and *Bacillus subtilis* ([@B1]--[@B3]). However, the same is not true for less genetically tractable organisms, including many intracellular pathogens such as *Francisella tularensis*. Riboswitches represent a potential solution, since they can be used to induce protein expression in diverse bacteria ([@B4]).

Riboswitches are RNA regulatory elements usually located in the 5′ untranslated region of mRNA. They possess an aptamer domain that binds to a specific ligand and an expression platform located downstream that undergoes a conformational change upon ligand binding, leading to an alteration of protein expression ([@B5]). Since riboswitches do not require the presence of accessory proteins ([@B6]) and can function independently of promoter identity, they can bypass pitfalls, such as promoter incompatibility or improper folding of accessory proteins, often encountered with exogenous expression of genetic control systems. In addition, riboswitches can be coupled with native promoters to drive expression ([@B4]), avoiding the incompatibility of foreign genetic regulation systems.

Unlike natural riboswitches, synthetic riboswitches do not require binding to a cellular metabolite, which allows for orthogonal genetic regulation that minimizes interruption of normal cellular function. Theophylline, a purine base structurally similar to caffeine and previously used as an antiasthmatic medication ([@B7]), has been used as a ligand for synthetic riboswitches. A number of theophylline-sensitive synthetic riboswitches have been reported as robust, broad-host-range genetic control elements ([@B4], [@B8], [@B9]). We thus anticipated that these riboswitches would be useful tools for studying the mechanisms of virulence in the Gram-negative bacterium *F*. *tularensis*.

*F*. *tularensis* is an intracellular bacterial pathogen that is the causative agent of the zoonotic disease tularemia, which is characterized by flu-like symptoms and exhibits a mortality rate of 30% ([@B10]) to 60% for the pneumonic form of the disease ([@B11]). *Francisella novicida* is closely related to *F. tularensis*, although it is rarely pathogenic to immunocompetent humans. *F. novicida* causes a tularemia-like disease in mice ([@B12]), possesses a genome that is 98% genetically identical to that of *F. tularensis* ([@B13], [@B14]), and has many virulence genes in common with *F. tularensis*. Additionally, *F. novicida*, like *F. tularensis*, exhibits the important virulence trait of replicating within host cells such as macrophages ([@B12], [@B15]). It is therefore often used as a model system to study *F. tularensis* biology.

Relatively little is known about the virulence factors required for *Francisella* pathogenesis, and the lack of genetic tools to modulate protein expression has hampered the investigation of protein functions ([@B16]). Many attempts to employ pre-existing tools from other organisms in *Francisella* have not been fruitful ([@B17]). We therefore set out to determine if riboswitches could be used to induce protein expression in *Francisella* and whether this system could be employed to modulate the expression of endogenous proteins during intracellular infection.

In this study, we show the efficacy of theophylline-sensitive synthetic riboswitches in inducing protein expression in *F. novicida* and highly virulent *F. tularensis* by using riboswitch-controlled β-galactosidase as a reporter. We also employed this system to control green fluorescent protein (GFP) expression during *F. novicida* infection of macrophages. We adapted this system to regulate the expression of an endogenous novel protein, FTN_0818, and showed that such control could functionally rescue the growth defect of an *FTN_0818* mutant in minimal medium. Furthermore, riboswitch-mediated induction of FTN_0818 during macrophage infection restored the ability of the mutant strain to replicate intracellularly. This is the first demonstration that a synthetic riboswitch can be used to efficiently control an endogenous virulence factor and rescue a virulence trait in an intracellular pathogen. We anticipate that synthetic riboswitches will prove useful in numerous applications of gene expression control to study the biology of intracellular bacteria.

RESULTS {#h1}
=======

We tested a panel of eight theophylline-sensitive synthetic riboswitches that regulate gene expression in a variety of bacteria ([@B4], [@B8], [@B9]). To determine if any of these riboswitches were functional in *F. novicida*, each was coupled to a β-galactosidase reporter driven by a strong *Francisella* promoter (P*~gro~*, the *groEL* promoter \[18\]) and cloned into the *Francisella-E. coli* shuttle vector pFNLTP6 ([@B19]). All reporter constructs exhibited at least a 5-fold increase in β-galactosidase activity in the presence of theophylline (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). Riboswitch E (E-Rs-βgal), which was rationally designed with the consensus ribosome binding site ([@B4]), exhibited a large dynamic range in *F. novicida* that was calculated by subtracting expression in the absence of theophylline from expression in the presence of theophylline ([Fig. 1](#fig1){ref-type="fig"}). Riboswitch F (F-Rs-βgal), selected from a library of randomized sequences ([@B8]), exhibited the lowest basal expression levels in the absence of theophylline ([Fig. 1](#fig1){ref-type="fig"}). Strains E-Rs-βgal and F-Rs-βgal were selected for further study because they exhibited the highest absolute level of gene expression in the presence of theophylline and the lowest background expression in the absence of theophylline, respectively. Each of these strains demonstrated ligand-dependent induction of β-galactosidase activity in a dose-dependent manner, even with as little as 0.1 mM theophylline ([Fig. 2](#fig2){ref-type="fig"}). These data demonstrate that riboswitches can be used effectively to modulate protein expression in *F. novicida*.

![Riboswitch-mediated control of β-galactosidase in *F. novicida*. Strains encoding riboswitch E (E-Rs-βgal) or F (F-Rs-βgal) upstream of *lacZ* were grown in the presence (●) or absence (○) of 1 mM theophylline to an OD~600~ between 0.7 and 0.8. β-galactosidase activity was measured in Miller units (left axis), and the activation ratio (green bar, right axis) was calculated by dividing the number of Miller units in the presence of theophylline by the number of Miller units in the absence of theophylline. The standard deviations of triplicate samples lie within the symbols. The data are representative of three independent experiments performed in triplicate.](mbo0061213820001){#fig1}

![Dose-dependent riboswitch-mediated induction of β-galactosidase. Strains E-Rs-βgal and F-Rs-βgal were subcultured and grown to exponential phase (OD~600~ between 0.7 and 0.8) in medium containing 0, 0.1, 0.5, 1, or 2 mM theophylline. β-Galactosidase activity was measured in Miller units. The data are representative of two independent experiments performed in triplicate.](mbo0061213820002){#fig2}

After verifying that the riboswitches function in *F. novicida*, we tested the feasibility of using them to control a reporter (GFP) during the bacterial infection of macrophages. We knew from previous work that strong expression levels would be required to detect fluorescence. We therefore chose riboswitch E, which induced the highest expression of β-galactosidase ([Fig. 1](#fig1){ref-type="fig"}), to drive GFP expression (strain E-Rs-GFP). As controls, we used strains constitutively expressing GFP under the control of the P*~gro~* promoter (GFP-pos) or promoterless GFP. We did not detect GFP expression in macrophages infected with strain GFP-neg or E-Rs-GFP in the absence of theophylline ([Fig. 3A and C](#fig3){ref-type="fig"}). In contrast, GFP expression was observed in macrophages infected with GFP-pos ([Fig. 3B](#fig3){ref-type="fig"}). Importantly, the E-Rs-GFP strain expressed GFP in the presence of 1 mM theophylline ([Fig. 3D](#fig3){ref-type="fig"}). These data demonstrate the ability of a theophylline-sensitive riboswitch to regulate the expression of a bacterial reporter during the infection of host cells.

![Riboswitch-mediated control of GFP (GFP-neg) in *F. novicida* during macrophage infection. RAW264.7 murine macrophages were infected at an MOI of 50:1 with *F. novicida* harboring *gfp* lacking a promoter (GFP-neg; panel A) or constitutively expressing *gfp* (GFP-pos; panel B) or the E-Rs-GFP riboswitch construct (panels C and D). At 30 min postinfection, medium without theophylline (panels A to C) or with 1 mM theophylline (panel D) was added and the macrophages were incubated at 37°C for 24 h and fixed. GFP (green) and DAPI-stained macrophage nuclei (blue) are shown. The magnification is ×100, and the scale bar represents 10 µm. The data are representative of three independent experiments in which at least 10 fields of view were analyzed for each condition.](mbo0061213820003){#fig3}

Having demonstrated the ability to control exogenous reporter proteins (β-galactosidase and GFP) with riboswitches in *F. novicida*, we set out to determine if this system could be used to control an endogenous protein. FTN_0818 is a novel protein involved in biotin metabolism that is required for *F. novicida* replication in minimal medium ([@B32]) and within macrophages ([@B20]). We engineered a strain in which FTN_0818 is under the control of riboswitch E (E-Rs-FTN_0818) and tested its ability to grow in Chamberlain's minimal medium. As expected, wild-type bacteria grew well while the Δ*FTN*\_*0818* mutant strain exhibited a growth defect. Even in the absence of theophylline, E-Rs-FTN_0818 replicated with wild-type kinetics (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material), likely because of the increased background expression associated with the use of riboswitch E ([Fig. 1](#fig1){ref-type="fig"}; see [Fig. S1](#figS1){ref-type="supplementary-material"}). It should be noted that the presence of theophylline mildly slowed the growth of both the wild-type and E-Rs-FTN_0818 strains, a phenotype observed in some types of bacteria. To reduce the basal expression of FTN_0818, we placed it under the control of riboswitch F (F-Rs-FTN_0818), which exhibited much lower basal expression in the β-galactosidase assays ([Fig. 1](#fig1){ref-type="fig"}). Indeed, in the absence of theophylline, the growth rate of strain F-Rs-FTN_0818 was nearly identical to that of the Δ*FTN*\_*0818* mutant strain ([Fig. 4](#fig4){ref-type="fig"}). In contrast, in the presence of 1 mM theophylline, the growth of F-Rs-FTN_0818 was rescued to a level similar to that of the wild type ([Fig. 4](#fig4){ref-type="fig"}). These data demonstrate that a theophylline-dependent synthetic riboswitch can be used to control the expression of an endogenous bacterial protein and functionally control bacterial growth.

![Theophylline-dependent rescue of bacterial replication. Growth rates are represented by cell density measured as OD~600~ every hour for 18 h. The wild-type (WT) and Δ*FTN*\_*0818* and F-Rs-FTN_0818 mutant strains were grown overnight (\~18 h) in TSB. Cultures were washed and then diluted in Chamberlain's minimal medium to an OD~600~ of 0.03 in the presence or absence of 1 mM theophylline. The standard deviations of triplicate samples lie within the areas of the symbols.](mbo0061213820004){#fig4}

The ultimate goal of this work was to modulate endogenous protein expression in the context of an intracellular infection to control and study virulence traits. To test the efficacy of this approach, we performed macrophage infections to determine whether theophylline-induced expression of FTN_0818 could rescue the intracellular growth defect of the Δ*FTN*\_*0818* mutant strain. Wild-type bacteria exhibited robust intracellular replication in the absence or presence of theophylline, demonstrating that this compound did not adversely affect this strain ([Fig. 5](#fig5){ref-type="fig"}). In contrast, the Δ*FTN*\_*0818* mutant strain was unable to replicate to significant levels. Similarly, strain F-Rs-FTN_0818 did not replicate to high levels in the presence or absence of theophylline, suggesting that the expression level of FTN_0818 induced by this riboswitch was insufficient to promote intracellular bacterial replication ([Fig. 5](#fig5){ref-type="fig"}). In contrast, the E-Rs-FTN_0818 strain exhibited very low level replication in the absence of theophylline but robust replication similar to that of the wild-type strain in the presence of 2 mM theophylline ([Fig. 5](#fig5){ref-type="fig"}). To our knowledge, these data are the first demonstration of the use of synthetic riboswitches to control the expression of a native bacterial virulence factor during the infection of host cells.

![Riboswitch-mediated control of *FTN_0818* facilitates intracellular replication. RAW264.7 murine macrophages were infected with the indicated *F. novicida* strains at an MOI of 20:1 in the presence of 0, 1, or 2 mM theophylline. Macrophages were lysed at 30 min and 24 h postinfection and plated to enumerate the intracellular CFU. Fold replication was calculated by dividing the number of CFU at 24 h postinfection by the number of CFU at 30 min. Bars represent the average fold replication of the strains, and error bars depict the standard deviations. The data are representative of four independent experiments. Asterisks indicate a significant difference in fold replication from that of the Δ*FTN*\_*0818* mutant strain in the presence of the indicated concentration of theophylline (\*\*\*, *P* \< 0.0005). WT, wild type.](mbo0061213820005){#fig5}

To test whether theophylline-dependent synthetic riboswitches function in highly virulent species of *Francisella*, we tested E-Rs-βgal in *F. tularensis* strain SchuS4. As depicted in [Fig. 6](#fig6){ref-type="fig"}, riboswitch E induced β-galactosidase expression in a dose-dependent manner in *F. tularensis* to levels similar to those in *F. novicida*. This clearly demonstrates the utility of a theophylline-dependent synthetic riboswitch in inducing protein expression in a highly virulent *Francisella* strain, and taken together, these data highlight the utility of this system in controlling protein expression in intracellular pathogens.

![Riboswitch E controlling β-galactosidase activity in *F. novicida* and *F. tularensis*. *F. novicida* strain E-Rs-βgal and *F. tularensis* strain E-Rs-βgal were subcultured and grown to exponential phase (OD~600~ of \~0.7 to 0.8) in medium containing 0, 0.5, 1, or 2 mM theophylline. β-galactosidase activity was measured in Miller units. The data are representative of two independent experiments performed in triplicate.](mbo0061213820006){#fig6}

DISCUSSION {#h2}
==========

In this study, we demonstrated the ability to induce protein expression in intracellular bacteria by using a synthetic riboswitch. Our synthetic riboswitches are induced by theophylline, a nonendogenous small molecule, and offer an orthogonal system for protein expression that minimizes interactions with natural biochemical pathways. Furthermore, the dose-dependent nature of these synthetic riboswitches allows tunable control over protein expression. This system was recently used to study a potential drug target in *Streptococcus pyogenes* ([@B21]) and to control gene expression in mycobacteria ([@B22]). Importantly, we have demonstrated the utility of this system in controlling proteins involved in virulence during intracellular infection. These riboswitches function in a broad range of bacteria and should therefore be easily applied, and highly useful, in studying the virulence strategies of numerous intracellular pathogens.

The riboswitch system overcomes problems encountered when adapting genetic tools from other organisms to *Francisella*. A possible explanation for the difficulty of transporting genetic tools from other organisms may lie partly in the unique α subunits of the RNA polymerase (RNAP) of *Francisella*. The α subunit serves as the initiator of RNAP assembly and binds to a supplementary promoter element (the UP element) upstream of the −35 recognition site ([@B23]). In most bacteria, the RNAP holoenzyme contains a dimer of identical α subunits ([@B24]). However, in the *Francisella* genus, the α subunits are encoded by two distinct genes, yielding two unique variants of the RNAP α subunit ([@B25]). Given the fundamental role of the α subunit in transcriptional regulation ([@B26]), the inefficient transcription of foreign promoters in *Francisella* may be attributed to the differences in RNAP. Riboswitches offer a solution to this problem, since they are readily coupled to native promoters ([@B4]).

We used this riboswitch system to control FTN_0818, an endogenous *Francisella* protein that is involved in biotin metabolism and is required for growth in minimal medium and intracellular replication in macrophages. When FTN_0818 expression was induced with theophylline in minimal medium, riboswitch F (F-Rs-FTN_0818) was sufficient to elicit a wild-type growth phenotype ([Fig. 4](#fig4){ref-type="fig"}). Interestingly, when stronger riboswitch E was used, even in the absence of theophylline, the strain exhibited a wild-type phenotype (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). This demonstrated that the background level of FTN_0818 expression induced by riboswitch E was sufficient to facilitate growth in minimal medium. However, in macrophages, riboswitch E was necessary to allow wild-type replication levels in the presence of theophylline ([Fig. 5](#fig5){ref-type="fig"}). By varying the time at which theophylline is added to infected macrophages, this system should also be useful in determining at what stage of infection a specific protein, like FTN_0818, is required.

Control of protein expression through synthetic riboswitches during the infection of mammalian cells is an important capability that will likely garner further insight into the virulence of numerous pathogenic bacteria, including *Francisella*. We hypothesize that it will also be feasible to regulate bacterial protein expression in *in vivo* systems by using synthetic riboswitches. Theophylline is an FDA-approved drug and has been tested in mouse models ([@B27], [@B28]). By extrapolating previous data correlating drug dosages with concentrations in blood serum ([@B28]), we have determined that it is theoretically possible to achieve concentrations in serum that are sufficient for the induction of protein expression without exceeding lethal doses of theophylline. Given the lack of tools to regulate the *in vivo* expression of proteins in *Francisella*, as well as many other intracellular pathogens, the development of riboswitches to be used in animal models is an avenue that merits further investigation. Taken together, the results presented here demonstrate the utility of synthetic riboswitches in studying virulence traits of intracellular bacteria and can be applied to a diverse set of difficult-to-study pathogens such as *Ehrlichia chaffeensis*, *Anaplasma phagocytophilum*, and *Orientia tsutsugamushi*, as well as future emerging pathogens.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and conditions. {#h3.1}
---------------------------------

The bacterial strains used in this study are listed in [Table 1](#tab1){ref-type="table"}. Plasmid manipulations were performed by using *E. coli* MDS42 (Scarab Genomics, Madison, WI) transformed via electroporation. All experiments were performed with *F. novicida* strain U112 ([@B15]) (a gift from Denise Monack, Stanford University, Stanford, CA) or related strains and *F. tularensis* strain SchuS4. *F. novicida* overnight cultures were grown on a rolling drum at 37°C in tryptic soy broth (TSB; Difco/BD, Sparks, MD) supplemented with 0.2% l-cysteine (Sigma-Aldrich, St. Louis, MO). Growth assays were performed with Chamberlain's minimal medium as previously described ([@B29]). For plating on solid medium, modified Mueller-Hinton (mMH; Difco/BD) plates supplemented with 0.025% ferric pyrophosphate (Sigma-Aldrich), 0.1% glucose, and 0.1% l-cysteine were used. When appropriate, kanamycin (Kan; Fisher Scientific, Fair Lawn, NJ) was added to the medium at a concentration of 30 µg ml^−1^.

###### 

Bacterial strains and plasmids used in this study

  Strain or plasmid           Description                                                                            Source
  --------------------------- -------------------------------------------------------------------------------------- ------------
  Strains                                                                                                            
      U112                    Wild-type *F. novicida*                                                                D. Monack
      Δ*FTN*\_*0818* mutant   U112 with *FTN_0818* removed by allelic exchange                                       [@B32]
      SchuS4                  Wild-type *F. tularensis*                                                              
      E-Rs-FTN_0818           Δ*FTN*\_*0818* mutant strain complemented with *FTN_0818* downstream of riboswitch E   This study
      F-Rs-FTN_0818           Δ*FTN*\_*0818* mutant strain complemented with *FTN_0818* downstream of riboswitch F   This study
      E-Rs-GFP                U112 containing plasmid pCKR34                                                         This study
      E-Rs-βgal               U112 containing plasmid pCKR47                                                         This study
      F-Rs-βgal               U112 containing plasmid pCKR43                                                         This study
      GFP-neg                 U112 containing plasmid pFNLTP6-NP (GFP negative control)                              This study
      GFP-pos                 U112 containing plasmid pFNLTP6-gro-gfp (GFP positive control)                         This study
  Plasmids                                                                                                           
      pFNLTP6-gro-gfp         *Francisella-E. coli* shuttle vector with *gro* promoter controlling *gfp*             [@B19]
      pFNLTP6-NP              *Francisella-E. coli* shuttle vector with promoter deleted                             This study
      pCKR34                  pFNLTP6 derivative with riboswitch E controlling *gfp*                                 This study
      pCKR43                  pFNLTP6 derivative with riboswitch F controlling *lacZ*                                This study
      pCKR47                  pFNLTP6 derivative with riboswitch E controlling *lacZ*                                This study

Cloning and mutagenesis. {#h3.2}
------------------------

The plasmids used in this study are listed in [Table 1](#tab1){ref-type="table"}. Synthetic oligonucleotide primers were purchased from Integrated DNA Technologies (Coralville, IA). DNA polymerase and restriction enzymes were purchased from New England Biolabs (Ipswich, MA). Previously published theophylline synthetic riboswitches ([@B4], [@B8], [@B9]) were adapted to *F. novicida* through the integration of a *Francisella* promoter. Riboswitch-controlled *lacZ* gene constructs under the control of the strong promoter P*~gro~* were cloned into an *E. coli-F. novicida* shuttle vector, pFNLTP6-gro-gfp, by using the PacI and BamHI restriction sites ([@B19]) (a gift from Thomas C. Zahrt, Medical College of Wisconsin, Milwaukee, WI). Riboswitches were amplified from previously reported plasmids ([@B4], [@B8], [@B9]) and assembled by PCR downstream of the *Francisella* promoter P*~gro~* and upstream of *lacZ* flanked by PacI and BamHI sites. After restriction enzyme digestion and ligation, constructs were transformed into *E. coli* MDS42. Plasmids were then extracted by using a Plasmid Midi-Prep kit (Qiagen, Germantown, MD). *F. novicida* U112 or *F. tularensis* SchuS4 was transformed as previously described ([@B30]). Plasmids for *gfp* were prepared as described above for *lacZ*. Sequences were verified by DNA sequencing (MWG Operon, Huntsville, AL). Riboswitch-mediated complement constructs of Δ*FTN*\_*0818* to be integrated into the *F. novicida* genome were generated by overlap PCR assembly of P*~gro~*-driven riboswitch E or F (see sequences in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material) upstream of FTN_0818, followed by a Kan resistance cassette and flanked by sequences homologous to a region of the genome known to accept genomic additions without disrupting normal cell function (nucleotides 818016 to 818037 and 818649 to 818670). Transformation of plasmid DNA or allelic exchange of linear DNA was performed as previously described ([@B30]). Briefly, a 1-ml aliquot of an overnight culture was added to 50 ml of TSB supplemented with 0.2% cysteine and grown at 37°C with shaking for 2 to 4 h until the optical density at 600 nm (OD~600~) was \~0.8 to 1.0. Cells were then harvested by centrifugation, and the cell pellet was resuspended in 5 ml of room temperature transformation buffer ([@B17]). Plasmid or linear DNA (\~1 µg) was added to 200-µl aliquots of resuspended cells and incubated at 37°C on a rolling drum for 20 min. One milliliter of TSB plus 0.2% cysteine was added, followed by another 2 h of incubation at 37°C on a rotary wheel. Cultures were then concentrated to 200 µl by centrifugation at 5,000 × *g* and plated on selective mMH medium.

Bacterial growth curves. {#h3.3}
------------------------

To measure bacterial growth, mutant, wild-type, and riboswitch strains ([Table 1](#tab1){ref-type="table"}) incubated overnight in TSB plus 0.2% cysteine were centrifuged at 15,294 × *g* for 2 min at room temperature. Cell pellets were resuspended in Chamberlain's minimal medium ([@B29]) and then subcultured in minimal medium with or without theophylline to an OD~600~ of 0.03. Subcultures were aliquoted (150 µl) into the wells of a 96-well plate and incubated overnight at 37°C with shaking in a plate reader (Bio-Tek Synergy MX, Winooski, VT). The OD~600~ was recorded every hour for 18 h in triplicate wells.

β-Galactosidase assay. {#h3.4}
----------------------

β-Galactosidase assays were performed as previously described ([@B31]), with the following modifications. Strains were cultured overnight at 37°C with shaking. Cells were then diluted (culture/medium) 1:30 (0 mM theophylline) or 1:25 (1 mM theophylline) into TSB containing Kan (30 µg/ml) and 0 or 1 mM theophylline to an OD~600~ of \~0.7 to 0.8. Theophylline and *o*-nitrophenyl-β-d-galactopyranoside were purchased from Sigma-Aldrich. Dose-response assays were performed as described above with the addition of various concentrations of theophylline and dilutions of 1:30 (0 and 0.25 mM theophylline), 1:27 (0.5 mM theophylline), and 1:21 (2 mM theophylline). These volumes were used to compensate for small decreases in the growth rate with increasing concentrations of theophylline.

Macrophage infections. {#h3.5}
----------------------

For infection, RAW264.7 murine macrophages (ATCC, Manassas, VA) were seeded into the wells of a chambered cover glass (CultureWell; Invitrogen, Carlsbad, CA) at 1 × 10^5^ cells per well and incubated overnight in Dulbecco's modified Eagle medium (high glucose, l-glutamine; DMEM; Lonza, Walkersville, MD) supplemented with 10% heat-inactivated fetal calf serum (FCS; HyClone, Logan, UT) at 37°C with 5% CO~2~. The medium was then removed, and the macrophages were infected with overnight cultures of various GFP-expressing strains ([Table 1](#tab1){ref-type="table"}) that were diluted in DMEM--10% FCS to achieve a multiplicity of infection (MOI) of 50 CFU of bacteria per macrophage. The plates were centrifuged for 15 min at 233 × *g* at room temperature and then incubated for 30 min. The macrophages were then washed twice with DMEM and returned to incubation overnight (18 to 24 h). Next, macrophages were rinsed twice with sterile phosphate-buffered saline (PBS) and fixed by incubation in 4% paraformaldehyde (PFA) in PBS for 20 min at room temperature. The cells were again rinsed twice with PBS to wash away the PFA. To measure bacterial replication, RAW264.7 macrophages were infected as described above, with the following differences. Macrophages were seeded into the wells of 24-well tissue culture plates at 7.5 × 10^5^ cells/well and infected at an MOI of 20 CFU per macrophage in DMEM--10% FCS containing 100 µg/ml gentamicin (Teknova, Hollister, CA) with or without 1 mM theophylline. Macrophages were then lysed with 1% saponin (Alfa Aesar, Heysham, Lancs, United Kingdom) in PBS without calcium or magnesium (Lonza, Walkersville, MD) at 30 min or 24 h. To quantify the bacterial load within macrophages at each time point, serial dilutions of the macrophage lysates were plated onto modified mMH agar plates and incubated overnight at 37°C. Finally, the *n*-fold replication of each strain was calculated (CFU at 24 h/CFU at 30 min).

Microscopy. {#h3.6}
-----------

Fluorescence microscopy was performed with an Eclipse Ti microscope coupled with the Nikon Elements software package (Nikon). Image capture was performed with an Evolve EM charge-coupled device (Photometrics) by using a CFI Apo 100× (numerical aperture of 1.49) objective (Nikon) with an Intensilight epifluorescence source (Nikon). Data acquisition utilized the Nikon Perfect Focus System, which allows the capture of multipoint Z-stack data without loss of focus. Z-stack images in 10 fields of view were taken for each construct by using the fluorescein isothiocyanate (FITC) and 4\',6-diamidino-2-phenylindole (DAPI) Chroma filter cubes to detect GFP and macrophage nuclei, respectively. Z-stacks probed a 5-µm section of the macrophages at 0.4 µm per slice. The FITC exposure time was 300 ms, while the DAPI exposure time was 50 ms. Images of the negative control were used as a reference to eliminate background fluorescence. Settings from the negative control were propagated to all images to allow accurate comparison. False color was applied to aid in analysis.

Statistics. {#h3.7}
-----------

Macrophage replication data were analyzed for significance by using the unpaired Student *t* test with two degrees of freedom.

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

Theophylline-dependent synthetic riboswitches controlling β-galactosidase in *F. novicida*. Strains encoding riboswitches A to G upstream of *lacZ* were grown in the presence (■) or absence (□) of 1 mM theophylline to an OD~600~ between 0.7 and 0.8. β-galactosidase activity was measured in Miller units (*y* axis). The activation ratio (not shown) was calculated by dividing the number of Miller units in the presence of theophylline by the number of Miller units in the absence of theophylline and are 15, 13, 7, 19, 9, 7, 7, and 7 for riboswitches A, B, C, D, E, E\*, F, and G, respectively. The standard deviations of triplicate samples are represented by error bars. The data are representative of three independent experiments performed in triplicate. Download [Figure S1, TIF file, 5.5 MB](/lookup/suppl/doi:10.1128/mBio.00253-12/-/DCSupplemental/mbo006121382sf01.tif).

###### 

Figure S1, TIF file, 5.5 MB

###### 

Riboswitch E controlling *FTN_0818* in minimal medium. Growth rates are represented by cell density measured as OD~600~ every hour for 18 h. The wild-type and Δ*FTN*\_*0818* and E-Rs-FTN_0818 mutant strains were grown overnight (\~18 h) in TSB. Cultures were washed and then diluted in Chamberlain's minimal medium to an OD~600~ of 0.03 in the absence or presence of 1 mM theophylline. Standard deviations of triplicate samples lie within the areas of the symbols. Download [Figure S2, TIF file, 3.8 MB](/lookup/suppl/doi:10.1128/mBio.00253-12/-/DCSupplemental/mbo006121382sf02.tif).

###### 

Figure S2, TIF file, 3.8 MB

###### 

Riboswitch sequences

###### 

Table S1, DOC file, 0.1 MB.
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During review of this manuscript, LoVullo et al. (Appl Environ Microbiol. 78:6883--6889, 2012) described a Tet-based inducible system for use in Francisella.
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